Dr. Cecelia L. Calhoun, MD
Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)
At a glance
- Medical school
- Wayne State University School of Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: Wayne State University School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Hematology & Oncology Physician primary
MO license 2015030411 -
Pediatrics Physician
MO license 2015030411
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Yale-New Haven Hospital New Haven, CT
Medical groups
- Yale University (2,645 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 4 companies reported 9 payments worth $1,002 in total to this clinician.
| Pfizer Inc. | $627 |
|---|---|
| Agios Pharmaceuticals, Inc. | $208 |
| AbbVie Inc. | $118 |
| Celgene Corporation | $49.01 |
| Food and Beverage | $651 |
|---|---|
| Travel and Lodging | $351 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Jul 31, 2025 | Travel and Lodging travel to New York, NY · in-kind | $301 |
| Pfizer Inc. Jul 31, 2025 | Travel and Lodging travel to New York, NY · in-kind | $50.46 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $9,660 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
E.r. Squibb & Sons, L.l.c. · Recruiting · NCT06481306 - A Phase 1/2a, First-in-human, Randomized, Double-blinded, Placebo-controlled, Dose-finding Study in Healthy Volunteers and Participants with Sickle Cell Disease to Evaluate the Pharmacokinetics, Pharmacodynamics, Safe…
E.r. Squibb & Sons, L.l.c.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.